Zobrazeno 1 - 10
of 87
pro vyhledávání: '"J. Anthony Child"'
Autor:
Jennifer L. J. Heaney, Alex Richter, Stella Bowcock, Guy Pratt, J. Anthony Child, Graham Jackson, Gareth Morgan, Ingemar Turesson, Mark T. Drayson
Publikováno v:
Haematologica, Vol 105, Iss 4 (2020)
Externí odkaz:
https://doaj.org/article/97bd550151574dbaa123dda2ff5c2869
Autor:
Punit Yadav, Paul Cockwell, Mark Cook, Jennifer Pinney, Hannah Giles, Yu Sandar Aung, David Cairns, Roger G. Owen, Faith E. Davies, Graham H. Jackson, J. Anthony Child, Gareth J. Morgan, Mark T. Drayson
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background Renal impairment (RI) is common in multiple myeloma (MM) and is associated with poor survival. This study reports the associations between renal function and disease characteristics including serum free light chain (FLC) level at
Externí odkaz:
https://doaj.org/article/77ae3687aa524aabacbd6e89b3855e2f
Autor:
Ruth M. de Tute, Andy C. Rawstron, Walter M. Gregory, J. Anthony Child, Faith E. Davies, Sue E. Bell, Gordon Cook, Alexander J. Szubert, Mark T. Drayson, Graham H. Jackson, Gareth J. Morgan, Roger G. Owen
Publikováno v:
Haematologica, Vol 101, Iss 2 (2016)
Externí odkaz:
https://doaj.org/article/60d5de834006459097fe542a146e6694
Autor:
Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, Sue E. Bell, Alexander J. Szubert, Nuria Navarro Coy, Gordon Cook, Sylvia Feyler, Peter R.E. Johnson, Claudius Rudin, Mark T. Drayson, Roger G. Owen, Fiona M. Ross, Nigel H. Russell, Graham H. Jackson, J. Anthony Child
Publikováno v:
Haematologica, Vol 97, Iss 3 (2012)
Background Thalidomide is active in multiple myeloma and is associated with minimal myelosuppression, making it a good candidate for induction therapy prior to high-dose therapy with autologous stem-cell transplantation.Design and Methods Oral cyclop
Externí odkaz:
https://doaj.org/article/041499dacc9f47dd98b2ea06bd51cabf
Autor:
Gareth J. Morgan, Faith E. Davies, J. Anthony Child, Graham H. Jackson, Walter M. Gregory, Zoe J. Konn, GianPaolo Dagrada, Laura Chiecchio, William J. Tapper, Christopher P. Wardell, Brian A. Walker, Fiona M. Ross, Kevin D. Boyd
PDF file - 9KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0906e60010d1362530a205b47732c7e4
https://doi.org/10.1158/1078-0432.22445882.v1
https://doi.org/10.1158/1078-0432.22445882.v1
Autor:
Gareth J. Morgan, Faith E. Davies, J. Anthony Child, Graham H. Jackson, Walter M. Gregory, Zoe J. Konn, GianPaolo Dagrada, Laura Chiecchio, William J. Tapper, Christopher P. Wardell, Brian A. Walker, Fiona M. Ross, Kevin D. Boyd
PDF file - 20KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ebafa520226ba24d482e775aee68555
https://doi.org/10.1158/1078-0432.22445885.v1
https://doi.org/10.1158/1078-0432.22445885.v1
Autor:
Gareth J. Morgan, Faith E. Davies, J. Anthony Child, Graham H. Jackson, Walter M. Gregory, Zoe J. Konn, GianPaolo Dagrada, Laura Chiecchio, William J. Tapper, Christopher P. Wardell, Brian A. Walker, Fiona M. Ross, Kevin D. Boyd
Purpose: Regions on 1p with recurrent deletions in presenting myeloma patients were examined with the purpose of defining the deletions and assessing their survival impact.Experimental Design: Gene mapping, gene expression, FISH, and mutation analyse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54326affbc26a4607649395fe27c12ac
https://doi.org/10.1158/1078-0432.c.6520583
https://doi.org/10.1158/1078-0432.c.6520583
Autor:
Gareth J. Morgan, Faith E. Davies, J. Anthony Child, Graham H. Jackson, Walter M. Gregory, Zoe J. Konn, GianPaolo Dagrada, Laura Chiecchio, William J. Tapper, Christopher P. Wardell, Brian A. Walker, Fiona M. Ross, Kevin D. Boyd
PDF file - 26KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1111c1c49347b7ca5ae121b8b03563e6
https://doi.org/10.1158/1078-0432.22445888
https://doi.org/10.1158/1078-0432.22445888
Autor:
Charles Agbuduwe, Gulnaz Iqbal, David Cairns, Tom Menzies, Janet Dunn, Walter Gregory, Martin Kaiser, Roger Owen, Charlotte Pawlyn, J. Anthony Child, Faith Davies, Gareth J. Morgan, Graham H. Jackson, Mark T. Drayson, Supratik Basu
Immunoglobulin D (IgD) myeloma is a subtype often considered to have adverse features and inferior survival, but there is a paucity of data from large clinical studies. We compare the clinical characteristics and outcomes of patients with IgD myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49fe75b4561cef1c28332680e8a2ed8a
https://eprints.whiterose.ac.uk/189006/1/advancesadv2022007608.pdf
https://eprints.whiterose.ac.uk/189006/1/advancesadv2022007608.pdf
Autor:
Martin Kaiser, Anna Hockaday, David A Cairns, J. Anthony Child, Walter M Gregory, John R Jones, Mark T. Drayson, Charlotte Bradbury, Zoe Craig, Graham Jackson, Gareth J. Morgan, Andrea Paterson, Matthew W Jenner, Gordon Cook, Faith E. Davies, Charlotte Pawlyn, Roger G. Owen
Publikováno v:
Blood. 136:1091-1104
Newly diagnosed multiple myeloma (NDMM) patients treated with immunomodulatory drugs are at high risk of venous thromboembolism (VTE), but data are lacking from large prospective cohorts. We present thrombosis outcome data from Myeloma IX (n = 1936)